Search research articles
Contact Us
Filters
Showing results (51-60 of 103) with videos related to
Page
of 11
Sort By:
Psychopharmacology
|
September 20, 2025
Lamotrigine is not associated with differential clinical outcomes in a real-world sample of patients with unipolar depression receiving ketamine or esketamine
Mia C Santucci, Rachel B Katz, Brian Pittman, et al.
Journal of Affective Disorders
|
October 19, 2017
Acute psychoactive effects of intravenous ketamine during treatment of mood disorders: Analysis of the Clinician Administered Dissociative State Scale
Gerrit I van Schalkwyk, Samuel T Wilkinson, Larry Davidson, et al.
Biological Psychiatry
|
December 12, 2018
Leveraging Neuroplasticity to Enhance Adaptive Learning: The Potential for Synergistic Somatic-Behavioral Treatment Combinations to Improve Clinical Outcomes in Depression
Samuel T Wilkinson, Paul E Holtzheimer, Shan Gao, et al.
The American Journal of Psychiatry
|
August 2, 2014
Delirium presenting as mania in a patient with end-stage COPD
Samuel T Wilkinson, Shin-Bey Chang, Teresa Foley, et al.
General Hospital Psychiatry
|
July 11, 2024
Blood pressure changes during ketamine infusion for the treatment of depression
Mina Ansari, Brian Pittman, Daniel S Tylee, et al.
JAMA Psychiatry
|
July 2, 2020
Prevalence of Treatment for Depression Among US Adults Who Screen Positive for Depression, 2007-2016
Taeho Greg Rhee, Samuel T Wilkinson, David C Steffens, et al.
JAMA Psychiatry
|
May 24, 2023
Trends in Illicit Ketamine Seizures in the US From 2017 to 2022
Joseph J Palamar, Samuel T Wilkinson, Thomas H Carr, et al.
Journal of the American Geriatrics Society
|
June 18, 2019
Associations of Adverse Childhood Experiences with Past-Year DSM-5 Psychiatric and Substance Use Disorders in Older Adults
Taeho Greg Rhee, Lisa C Barry, George A Kuchel, et al.
The Journal of Clinical Psychiatry
|
August 1, 2018
Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital
Samuel T Wilkinson, Rachel B Katz, Mesut Toprak, et al.
Journal of Affective Disorders
|
August 29, 2018
Serum and plasma brain-derived neurotrophic factor and response in a randomized controlled trial of riluzole for treatment resistant depression
Samuel T Wilkinson, Carly Kiselycznyk, Mounira Banasr, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 103) with videos related to
Sort By:
Page
of 11
Psychopharmacology
|
September 20, 2025
Lamotrigine is not associated with differential clinical outcomes in a real-world sample of patients with unipolar depression receiving ketamine or esketamine
Mia C Santucci, Rachel B Katz, Brian Pittman, et al.
Journal of Affective Disorders
|
October 19, 2017
Acute psychoactive effects of intravenous ketamine during treatment of mood disorders: Analysis of the Clinician Administered Dissociative State Scale
Gerrit I van Schalkwyk, Samuel T Wilkinson, Larry Davidson, et al.
Biological Psychiatry
|
December 12, 2018
Leveraging Neuroplasticity to Enhance Adaptive Learning: The Potential for Synergistic Somatic-Behavioral Treatment Combinations to Improve Clinical Outcomes in Depression
Samuel T Wilkinson, Paul E Holtzheimer, Shan Gao, et al.
The American Journal of Psychiatry
|
August 2, 2014
Delirium presenting as mania in a patient with end-stage COPD
Samuel T Wilkinson, Shin-Bey Chang, Teresa Foley, et al.
General Hospital Psychiatry
|
July 11, 2024
Blood pressure changes during ketamine infusion for the treatment of depression
Mina Ansari, Brian Pittman, Daniel S Tylee, et al.
JAMA Psychiatry
|
July 2, 2020
Prevalence of Treatment for Depression Among US Adults Who Screen Positive for Depression, 2007-2016
Taeho Greg Rhee, Samuel T Wilkinson, David C Steffens, et al.
JAMA Psychiatry
|
May 24, 2023
Trends in Illicit Ketamine Seizures in the US From 2017 to 2022
Joseph J Palamar, Samuel T Wilkinson, Thomas H Carr, et al.
Journal of the American Geriatrics Society
|
June 18, 2019
Associations of Adverse Childhood Experiences with Past-Year DSM-5 Psychiatric and Substance Use Disorders in Older Adults
Taeho Greg Rhee, Lisa C Barry, George A Kuchel, et al.
The Journal of Clinical Psychiatry
|
August 1, 2018
Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital
Samuel T Wilkinson, Rachel B Katz, Mesut Toprak, et al.
Journal of Affective Disorders
|
August 29, 2018
Serum and plasma brain-derived neurotrophic factor and response in a randomized controlled trial of riluzole for treatment resistant depression
Samuel T Wilkinson, Carly Kiselycznyk, Mounira Banasr, et al.
Page
of 11